References and Notes
<A NAME="RD08106ST-1">1</A>
Moncada S.
Higgs EA.
FASEB J.
1995,
9:
1319
<A NAME="RD08106ST-2">2</A>
Knowles RG.
Moncada S.
Biochem. J.
1994,
298:
249
<A NAME="RD08106ST-3">3</A>
Kawanaka Y.
Kobayashi K.
Kusuda S.
Tatsumi T.
Murot M.
Nishiyama T.
Hisaichi K.
Fujii A.
Hirai K.
Nak M.
Komeno M.
Odagaki Y.
Nakai H.
Toda M.
Bioorg. Med. Chem. Lett.
2003,
13:
1723 ; and references cited therein
<A NAME="RD08106ST-4A">4a</A>
Ueda S.
Terauchi H.
Yano A.
Iro M.
Matsumoto M.
Kawasaki M.
Bioorg. Med. Chem. Lett.
2004,
14:
313
<A NAME="RD08106ST-4B">4b</A>
Atkinson RN.
Moore L.
Tobin J.
King SB.
J. Org. Chem.
1999,
64:
3467
<A NAME="RD08106ST-5">5</A>
Moore WM.
Webber RK.
Fok KF.
Jerome GM.
Connor JR.
Manning PT.
Wyatt PS.
Misko TP.
Tjoeng FS.
Currie MG.
J. Med. Chem.
1996,
39:
669
<A NAME="RD08106ST-6A">6a</A>
Hagen TJ.
Bergmanis AA.
Kramer SW.
Fok KF.
Schmelzer AE.
Pitzele BS.
Swenton L.
Jerome GM.
Kornmeier CM.
Moore WM.
Branson LF.
Connor JR.
Manning PT.
Currie MG.
Hallinan EA.
J. Med. Chem.
1998,
41:
3675
<A NAME="RD08106ST-6B">6b</A>
Tsymbalov S.
Hagen TJ.
Moore WM.
Jerome GM.
Connor JR.
Manning PT.
Pitzele BS.
Hallinan EA.
Bioorg. Med. Chem. Lett.
2002,
12:
3337
<A NAME="RD08106ST-6C">6c</A>
Guthikonda NR.
Shah SK.
Pacholok SG.
Humes JL.
Mumford RA.
Grant SK.
Chabin RM.
Green BG.
Tsou N.
Ball R.
Fletcher DS.
Luell S.
MacIntyre DE.
MacCoss M.
Bioorg. Med. Chem. Lett.
2005,
15:
1997
<A NAME="RD08106ST-7">7</A>
Burden PM.
Synth. Commun.
1993,
23:
1195
<A NAME="RD08106ST-8A">8a</A>
Shankaran K.
Donnelly K.
Shah SK.
Guthikonda RN.
MacCoss M.
Humes JL.
Pacholok SG.
Grant SK.
Kelly TM.
Wong KK.
Bioorg. Med. Chem. Lett.
2004,
14:
4539
<A NAME="RD08106ST-8B">8b</A>
Shankaran K.
Donnelly KL.
Shah SK.
Caldwell CG.
Chen P.
Hagmann WK.
MacCoss M.
Humes JL.
Pacholok SG.
Kelly TM.
Grant SK.
Wong KK.
Bioorg. Med. Chem. Lett.
2004,
14:
5907
<A NAME="RD08106ST-8C">8c</A>
Gadreau C.
Foucaud A.
Tetrahedron Lett.
1974,
48:
4243
<A NAME="RD08106ST-9">9</A>
Benati L.
Bencivenni G.
Leardini R.
Minozzi M.
Nanni D.
Scialpi R.
Spagnolo P.
Zanardi G.
Rizzoli C.
Org. Lett.
2004,
6:
417
<A NAME="RD08106ST-10A">10a</A>
Postel D.
Nguyen Van Nhien A.
Pillon M.
Villa P.
Ronco G.
Tetrahedron Lett.
2000,
41:
6403
<A NAME="RD08106ST-10B">10b</A>
Nguyen Van Nhien A.
Ducatel H.
Len C.
Postel D.
Tetrahedron Lett.
2002,
43:
3805
<A NAME="RD08106ST-10C">10c</A>
Postel D.
Nguyen Van Nhien A.
Marco JL.
Eur. J. Org. Chem.
2003,
19:
3713
<A NAME="RD08106ST-10D">10d</A>
Dominguez L.
Nguyen Van Nhien A.
Tomassi C.
Len C.
Postel D.
Marco-Contelles JL.
J. Org. Chem.
2004,
69:
843
<A NAME="RD08106ST-10E">10e</A>
Nguyen Van Nhien A.
Tomassi C.
Len C.
Marco-Contelles JL.
Balzarini J.
Pannecouque C.
De Clercq E.
Postel D.
J. Med. Chem.
2005,
48:
4276
<A NAME="RD08106ST-11">11</A>
Ewing DF.
Goethals G.
MacKenzie G.
Martin P.
Ronco G.
Vanbaelinghem L.
Villa P.
Carbohydr. Res.
1999,
321:
190
<A NAME="RD08106ST-12">12</A>
(1
R
,3
R
,4
R
,5
R
)-5,6-Diamino-3,4-
O
-isopropylidene-7-aza-2-oxabicyclo[3.3.0]oct-6-ene (
8).
To a solution of compound 2 (0.20 g, 0.85 mmol) in 10 mL of THF-H2O (4:1) was added 0.25 g (0.93 mmol) of PPh3. After stirring overnight at r.t., the reaction mixture was evaporated and extracted
with Et2O and H2O. The aqueous layer was evaporated to give 0.16 g (89%) of 8 as a slight yellow syrup; [α]D
20 20 (c 0.17, CHCl3). IR (ATR): 2988, 1655, 1374, 1217, 1165, 1086, 1007, 877, 733 cm-1. 1H NMR (CDCl3): δ = 5.80 (d, 1 H, H-1, J
1,2 = 3.9 Hz), 4.60 (d, 1 H, H-2), 4.30 (d, 1 H, H-4, J
4,5a = 3.0 Hz), 3.72 (dd, 1 H, H-5a, J
5a,5b = 14.0 Hz), 3.67 (d, 1 H, H-5b), 1.53 (s, 3 H, CH3), 1.35 (s, 3 H, CH3). 13C NMR (CDCl3): δ = 168.2 (C=N), 112.9 (CH3
CCH3), 106.1 (C-1), 85.1 (C-4), 82.2 (C-2), 74.1 (C-3), 55.5 (C-5), 27.6, 27.3 (2 × CH3). HRMS: m/z calcd for C9H16N3O3 [M + H]+: 214.1192; found: 214.1196. Anal. Calcd for C9H15N3O3: C, 50.69; H, 7.09; N, 19.71. Found: C, 50.54; H, 6.95; N, 19.60.
<A NAME="RD08106ST-13">13</A>
Key Data for Compound 9.
13C NMR (CDCl3): δ = 173.4 (C=N, J
2
C-P = 9.0 Hz), 75.4 (C-3, J
3
C-P = 17.2 Hz), 14.4 [P(CH3)3, J
1
CH3-P = 66.0 Hz). MS: m/z = 288.14 [M + H]+.
<A NAME="RD08106ST-14">14</A>
3-Amino-3-deoxy-1,2-
O
-isopropylidene-α-
d-ribofurano-sidurono-3,5-lactam (
17).
White solid, mp 159-162 °C; [α]D
20 18 (c 0.11, CHCl3). 1H NMR (CD3OD): δ = 5.81 (d, 1 H, H-1, J
1,2 = 3.9 Hz), 4.60 (d, 1 H, H-2), 4.40 (d, 1 H, H-4, J
4,5a = 3.5 Hz), 3.65 (dd, 1 H, H-5a, J
5a,5b = 11.8 Hz), 3.32 (d, 1 H, H-5b), 1.56 (s, 3 H, CH3), 1.38 (s, 3 H, CH3). 13C NMR (CD3OD): δ = 176.4 (1 C, C=O), 112.8 (1 C, CH3
CCH3), 106.1 (1 C, C-1), 81.9 (1 C, C-2), 81.8 (1 C, C-4), 68.8 (1 C, C-3), 45.6 (1 C,
C-5), 26.4, 26.0 (2 C, CH3). IR (ATR): ν = 2959, 2932, 1716, 1659, 1465, 1382, 1233, 1166, 1098, 1082, 1001
cm-1. HRMS: m/z calcd for C9H14N2O4Na: 237.0851 [M + Na]+; found: 237.0850.
<A NAME="RD08106ST-15">15</A>
3,5-Diamino-3-
C
-carboxy-3,5-dideoxy-1,2-
O
-isopropyl-idene-α-
d-ribofuranose (
18).
White solid, mp 200 °C; [α]D
20 77 (c 0.21, H2O). 1H NMR (D2O): δ = 5.88 (d, 1 H, H-1, J
1,2 = 3.6 Hz), 4.55 (d, 1 H, H-2), 3.94 (dd, 1 H, H-4, J
4,5a = 1.8 Hz), 3.13 (dd, 1 H, H-5a, J
5a,5b = 13.3 Hz), 2.78 (dd, 1 H, H-5b, J
5b,4 = 9.9 Hz), 1.44 (s, 3 H, CH3), 1.27 (s, 3 H, CH3). 13C NMR (D2O): δ = 175.1 (1 C, C=O), 113.4 (1 C, CH3
CCH3), 105.9 (1 C, C-1), 83.3 (1 C, C-2), 80.3 (1 C, C-4), 68.5 (1 C, C-3), 40.1 (1 C,
C-5), 26.1, 25.7 (2 C, CH3). IR (ATR): ν = 2987, 2917, 1614, 1540, 1409, 1381, 1230, 1163, 1069, 1015, 883,
809 cm-1. HRMS: m/z calcd for C9H16N2O5Na: 255.0957 [M + Na]+; found: 255.0950.
<A NAME="RD08106ST-16">16</A>
(1
R
,3
R
,4
R
,5
R
)-5-{[1,2-
O
-Isopropylidene-α-
d-xylo-furanos-5-yl]amino}-6-amino-3,4-
O
-isopropylidene-7-aza-2-oxabicyclo[3.3.0]oct-6-ene (
21).
White solid, mp 125-128 °C; [α]D
20 18.2 (c 0.36, CHCl3). IR (ATR): 2989, 2901, 1655, 1384, 1217, 1167, 1073, 1014, 879, 858 cm-1. 1H NMR (CDCl3): δ = 5.89 (d, 1 H, H-1, J
1,2 = 3.6 Hz), 5.77 (d, 1 H, H-1′, J
1
′
,2
′ = 3.7 Hz), 4.62 (d, 1 H, H-2′), 4.52 (s, 1 H, H-4), 4.38 (d, 1 H, H-2), 4.14 (d,
1 H, H-4′, J
4
′
,3
′ = 2.7 Hz), 4.05 (d, 1 H, H-3′), 3.56 (s, 2 H, H-5′), 3.06 (d, 1 H, H-5a, J
5a,5b = 11.7 Hz), 2.77 (dd, 1 H, H-5b, J
5b,4 = 3.5 Hz), 1.48 (s, 3 H, CH3), 1.39 (s, 3 H, CH3), 1.29 (s, 3 H, CH3), 1.20 (s, 3 H, CH3). 13C NMR (CDCl3): δ = 164.9 (1 C, CN), 112.9, 111.5 (2 C, CH3
CCH3), 105.2, 104.8 (2 C, 2 C-1), 85.6 (1 C, C-2), 83.1 (1 C, C-4), 82.2 (1 C, C-2′),
77.9 (1 C, C-4′), 76.5 (2 C, C-3′, C-3), 58.2 (1 C, C-5′), 42.4 (1 C, C-5), 27.3 (1
C, CH3), 27.1 (1 C, CH3), 26.7 (1 C, CH3), 26.1 (1 C, CH3). HRMS: m/z calcd for C17H28N3O7: 386.1927 [M + H]+; found: 386.1908. Anal. Calcd for C17H27N3O7: C, 52.98; H, 7.06; N, 10.90. Found: C, 52.91; H, 7.04; N, 10.87.
<A NAME="RD08106ST-17">17</A>
3,5-Diamino-3-
C
-carboxy-3,5-dideoxy-3-
N
-[1′,2′-
O
-isopropylidene-α-
d-xylofuranos-5′-yl]-1,2-
O
-isopropyl-idene-α-
d-ribofuranose (
22).
White solid, mp 254-256 °C; [α]D
25 8.0 (c 0.21, CHCl3). IR (ATR): 2987, 2900, 1589, 1394, 1215, 1066 cm-1. 1H NMR (CD3OD): δ = 5.99 (d, 1 H, H-1′, J
1
′
,2
′ = 3.6 Hz), 5.95 (d, 1 H, H-1, J
1,2 = 3.8 Hz), 5.01 (d, 1 H, H-2), 4.49 (d, 1 H, H-2′), 4,22 (m, 2 H, H-4′, H-3′), 3.98
(t, 1 H, H-4, J
4,5 = 6.8 Hz), 3.12 (d, 2 H, H-5), 3.56 (dd, 2 H, H-5a′, J
5a,5b = 11.7 Hz, J
5a,4 = 6.3 Hz), 2.71 (dd, 1 H, H-5b′, J
5b,4 = 7.3 Hz), 1.56 (s, 3 H, CH3), 1.47 (s, 3 H, CH3), 1.38 (s, 3 H, CH3), 1.31 (s, 3 H, CH3). 13C NMR (CD3OD): δ = 174.6 (1 C, C=O), 112.3, 111.6 (2 C, CH3
CCH3), 106.8, 105.4 (2 C, C-1′, C-1), 85.2 (1 C, C-2′), 81.2 (1 C, C-2), 80.8 (1 C, C-4′),
77.8 (1 C, C-4), 76.5 (2 C, C-3′, C-3), 43.1 (1 C, C-5′), 40.9 (1 C, C-5), 26.4 (1
C, CH3), 26.2 (1 C, CH3), 25.7 (1 C, CH3), 25.5 (1 C, CH3). HRMS: m/z calcd for C17H28N2O9Na: 427.1693
[M + Na]+; found: 427.1685.